Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
4JUL

CuspAI closes at $2.6bn, EU fund circles

2 min read
11:24UTC

CuspAI closed in late June at $2.6bn with Bezos Expeditions and Kleiner Perkins and no UK backer; now EQT and the EU's Scaleup Europe Fund want in.

TechnologyDeveloping
Key takeaway

An EU sovereign fund is circling a UK AI winner that no British investor backed.

CuspAI's round formally closed in late June at a $2.6bn valuation, led by Bezos Expeditions and Kleiner Perkins, with no UK vehicle on the cap table 1. The Cambridge materials-discovery firm, which uses AI to design new materials, had signed those term sheets on 20 June ; the close confirms the figure without moving it.

EQT, the Swedish investment group the European Innovation Council (the EU's deep-tech funding body) appointed to run the bloc's new EUR5bn Scaleup Europe Fund, then entered advanced talks for a further CuspAI stake, reported on 3 July 2.

Britain spent the spring building sovereign vehicles to stop allied capital capturing its AI winners, after Fractile raised NATO and CIA venture money with no UK co-investor and Orbital Industries closed $50m with no UK lead . EQT would put an EU vehicle, not a US one, on the cap table of a company Britain's own funds passed over. The Scaleup Europe Fund holds EUR5bn; the UK's Sovereign AI Unit holds GBP500m, and has led none of the marquee 2026 rounds.

Deep Analysis

In plain English

CuspAI is a Cambridge company that uses artificial intelligence to design new materials, such as ones that capture carbon or remove harmful chemicals from water. It has just finished raising $2.6bn worth of shares from investors, but none of that money came from a British fund. Now EQT, a European investment firm managing €5bn of European Union government money, wants to buy an even bigger stake. 'No UK vehicle on the cap table' means no British-based investor owns a piece of the company. As CuspAI grows, the profits from its success will flow mostly to American and European investors rather than back into the UK.

Deep Analysis
Root Causes

The UK lacks a domestic growth-equity fund capable of writing $200m-plus cheques at Series C and beyond for deep tech. British Patient Capital, the British Business Bank's growth vehicle, is structured to allocate as a limited partner into other funds rather than write large direct cheques itself, so when a round the size of CuspAI's needs $400m in a single close, only sovereign wealth vehicles or US mega-funds have the balance sheet to supply it.

That capacity gap, not a lack of UK investor appetite, is why EQT's EU-backed fund can enter talks for a further stake while no comparable British vehicle appears on the term sheet.

What could happen next?
  • Precedent

    EQT's pursuit of a CuspAI stake sets a template for EU sovereign vehicles buying into UK deep-tech winners at the exact cheque size domestic funds cannot match.

First Reported In

Update #10 · AI takes record 44% as UK equity shrinks

FinSMEs / Sifted / FTI Consulting digest· 4 Jul 2026
Read original
Different Perspectives
Institute of Physics
Institute of Physics
The Institute has long argued STFC's national-laboratory infrastructure, not its grant programmes, is the binding constraint on UK physics output, and warns mothballing capacity like Clara removes capability that cannot be rebuilt on a four-year cycle. It represents the discovery-science community absorbing the reallocation the Bank's equity cheques do not touch.
Helsing
Helsing
The Munich-headquartered defence-AI firm chose Plymouth over Continental sites for a £350m manufacturing plant building underwater surveillance gliders, alongside its record raise. Its choice of postcode signals confidence in UK manufacturing capacity for defence hardware even as it looks abroad for the capital financing that hardware.
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
The three US growth-capital firms backed Helsing's $1.8bn round at an $18bn valuation, more than doubling the mark set only a year earlier, with demand reportedly exceeding the capital on offer. Their money, not a UK sovereign vehicle, is what funds the Plymouth plant, extending a pattern of foreign capital underwriting British defence-hardware manufacturing this cycle.
British Business Bank
British Business Bank
The Bank wrote its largest-ever direct life-sciences cheque into Alchemab and added a £6.5bn SME lending guarantee the same week UKRI confirmed the STFC cuts. It is deploying an April mandate change letting it lead venture rounds and invest directly up to £60m per company, treating equity extension rounds and small-business debt as newly within its risk appetite.
Daphni
Daphni
The Paris seed fund joined Speedinvest and three UK backers in Astral Systems' GBP23m Series A for modular fusion reactors, one of the round's five European co-investors betting on lab-to-market fusion ahead of any working commercial reactor. Unlike CuspAI's all-foreign cap table, this round kept a UK lead investor in Mercia Ventures.
EQT
EQT
EQT, appointed by the European Innovation Council to run the EUR5bn Scaleup Europe Fund, entered advanced talks for a further CuspAI stake reported on 3 July, the fund's first pursuit of a UK-founded winner. A closed deal would put EU sovereign capital, not a UK vehicle, on the cap table of a company Britain's own funds passed over.